M&A · Healthcare · Services-Home Health Care Services
Optum to acquire Amedisys Inc
Announced Jun 26, 2023 · Closed Aug 14, 2025
Deal value$3.29BEV $3.64B
Premium29.4%To unaffected price
EV / Adj. EBITDA17.1x
ConsiderationAll cash$101.00 per share
Transaction
- Acquirer
- Optum
- Target
- Amedisys Inc (AMED)
- Buyer type
- Strategic
- Offer price per share
- $101.00
- Enterprise value
- $3.64B
- Status
- Closed Aug 14, 2025
Deal protections
- Break fee (target pays)
- $125M · 3.8%
- Reverse fee (buyer pays)
- $250M · 7.6%
- Go-shop
- No-shop
- Financing
- No financing condition
Advisors
- To the acquirer
- Not disclosed
- To the target
- Guggenheim
- Guggenheim fee
- $37.0M
Sector context · Healthcare
- Comparable deals
- 85 in the prior 24 months
- Premium
- 29.4% vs. 50.0% sector median
- EV / Adj. EBITDA
- 17.1x vs. 19.3x sector median
- Break fee
- 3.8% vs. 3.5% sector median
Timeline
- AnnouncedJun 26, 2023
- Proxy filedJul 31, 2023
- Definitive proxyAug 10, 2023
- Shareholder voteSep 8, 2023
- ClosedAug 14, 2025
Valuation · fairness opinions
Discounted cash flow$63.75$103.25
Discounted cash flow$71.00$108.25
Trading comparables$77.00$99.00
Offer $101.00
Implied value per Amedisys Inc share by analysis, from Guggenheim.